Table 2.
Variable | High-dose group | Low-dose group | p-Value |
---|---|---|---|
Prerejection FS | 33.78 ± 2.391 | 33.52 ± 1.716 | 0.93 |
FS at time of diagnosis | 22.688 ± 13.638 | 23.944 ± 9.6469 | 0.94 |
LVEDD | 44.168 ± 6.5936 | 43.31 ± 9.2057 | 0.69 |
TR at time of diagnosis | 12 (3 moderate and 1 severe) | 37 (12 moderate and 1 severe) | 0.63 |
MR at time of diagnosis | 9 (1 moderate and 1 severe) | 29 (4 moderate and no severe) | 0.23 |
Mitral inflow abnormalities at time of diagnosis | 9 | 19 | 0.37 |
RAP pressure (mmHg) | 14.333 ± 6.4395 | 17.15 ± 6.9757 | 0.38 |
PCWP (mmHg) | 20.833 ± 4.9967 | 20.238 ± 6.6099 | 0.81 |
Pericardial or pleural effusions at the time of diagnosis | 12 | 7 | 0.23 |
Presence of TCD prior to rejection episode | 2 | 9 | 0.16 |
FS = fractional shortening; LVEDD = left ventricular end diastolic dimension; TR = tricuspid valve regurgitation; MR = mitral valve regurgitation; RAP = right atrial pressure; PCWP = pulmonary capillary wedge pressure; TCD = transplant coronary disease